Philippines News API

{
    "totalArticles": 219852,
    "articles": [
        {
            "id": "d9b03e6d342c576b3c8ff52d361f6b28",
            "title": "President Oaks Dedicates the Burley Idaho Temple",
            "description": "President Dallin H. Oaks of The Church of Jesus Christ of Latter-day Saints dedicated the Burley Idaho Temple on Sunday, January 11, 2025 — his first temple dedication as Church president.",
            "content": "President Dallin H. Oaks of The Church of Jesus Christ of Latter-day Saints dedicated the Burley Idaho Temple on Sunday, January 11, 2025 — his first temple dedication as Church president.\n“We dedicate and consecrate unto Thee and Thy Beloved Son thi... [14440 chars]",
            "url": "https://newsroom.churchofjesuschrist.org/article/president-oaks-dedicates-burley-idaho-temple",
            "image": "https://newsroom.churchofjesuschrist.org/media/640x480/20260110151716Nilsson__LES1121.jpg",
            "publishedAt": "2026-01-11T20:51:09Z",
            "lang": "en",
            "source": {
                "id": "c2bd588a4be9e7db819ad8feae5127e9",
                "name": "newsroom.churchofjesuschrist.org",
                "url": "https://newsroom.churchofjesuschrist.org"
            }
        },
        {
            "id": "3ce3492937d9a9fe7a65ce2f84be1059",
            "title": "Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference",
            "description": "The Investor Relations website contains information about Krystal Biotech, Inc.'s business for stockholders, potential investors, and financial analysts.",
            "content": "Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million\nRobust clinical pipeline with multibillion dollar opportunities and strong balance sheet for sustained growth\nPITTSBURGH, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. ... [8761 chars]",
            "url": "https://ir.krystalbio.com/news-releases/news-release-details/krystal-biotech-provides-business-update-44th-annual-jp-morgan",
            "image": "https://ir.krystalbio.com/sites/g/files/knoqqb89436/files/favicon-16x16.png",
            "publishedAt": "2026-01-11T18:03:51Z",
            "lang": "en",
            "source": {
                "id": "2a51979d24f93ec3bb68906fe48d1e71",
                "name": "Krystal Biotech, Inc",
                "url": "https://ir.krystalbio.com"
            }
        },
        {
            "id": "281d4afcf512ed2e6c621455b3f6f530",
            "title": "Krystal Biotech Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference",
            "description": "Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million",
            "content": "Preliminary 4Q 2025 VYJUVEK net revenue of $106 million to $107 million\nRobust clinical pipeline with multibillion dollar opportunities and strong balance sheet for sustained growth\nPITTSBURGH, Jan. 11, 2026 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. ... [8706 chars]",
            "url": "https://www.manilatimes.net/2026/01/12/tmt-newswire/globenewswire/krystal-biotech-provides-business-update-at-44th-annual-jp-morgan-healthcare-conference/2256728",
            "image": "https://www.manilatimes.net/manilatimes/uploads/images/2026/01/12/895508.png",
            "publishedAt": "2026-01-11T18:03:27Z",
            "lang": "en",
            "source": {
                "id": "e3ad8bbf7dbe3c3defc56a8393455066",
                "name": "The Manila Times",
                "url": "https://www.manilatimes.net"
            }
        }
    ]
}